Cambrex Corporation announced changes to its management team and Board of Directors to accelerate growth and further operational excellence, building upon its trusted reputation for the higher quality pharmaceutical development and manufacturing capabilities. The following appointments and new positions are effective immediately. Robert Green has been named Executive Vice President and Chief Financial Officer, succeeding Gregory Sargen, who will depart the company on January 31.

Mr. Green joins from General Electric Corporation, where he began his career in 1990 and was most recently CFO of GE Power, a global business unit with $35 billion in revenue operating in 180 countries. Shawn Cavanagh has been promoted to President and Chief Operating Officer, and will join the Company's Board of Directors. Shawn has served as EVP and Chief Operating Officer of Cambrex since 2011.

Stephan Haitz has been promoted to President, CDMO Sales & Marketing. Mr. Haitz joined Cambrex in 2014 and has served as Vice President, Sales & Business Development. Stephan previously held various sales and business development roles at Lonza and Solvias AG.

The Company's Board of Directors will now be comprised of Chairman Wayne Hewett, CEO Steven Klosk, President Shawn Cavanagh, Claes Glassell, who will be rejoining the Board, Permira Partners John Coyle and Henry Minello and Permira Principal Laura O'Donnell.